<DOC>
	<DOCNO>NCT00966888</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray type radiation kill tumor cell . Giving radiation therapy surgery may kill tumor cell remain surgery . It yet know whether radiation therapy effective observation mastectomy treat woman stage II breast cancer . PURPOSE : This randomized phase III trial study radiation therapy see well work compare standard therapy treat woman stage II breast cancer undergone mastectomy .</brief_summary>
	<brief_title>Radiation Therapy Standard Therapy Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy</brief_title>
	<detailed_description>OBJECTIVES : - Determine overall survival woman intermediate risk locoregional recurrence breast cancer treat ipsilateral chest wall adjuvant radiotherapy mastectomy . OUTLINE : This multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Beginning 12 week mastectomy 6 week adjuvant chemotherapy , patient undergo radiotherapy 5 day week 3-5 week absence disease progression unacceptable toxicity . - Arm II : Patients receive standard care observation . After completion study therapy , patient follow twice first year , annually 10 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unilateral invasive breast cancer pT1 , pN1 , M0 disease pT2 , pN1 , M0 disease pT2 , pN0 disease grade III histology and/or lymphovascular invasion Multifocal breast cancer meeting follow criterion : Largest discrete tumor ≥ 2 cm N0 Grade III histology and/or lymphovascular invasion No bilateral breast cancer Axillary node negative status axillary clearance , axillary node sampling , sentinel node biopsy Patients axillary node positive ( 13 positive node , include micrometastases* &gt; 0.2 mm ≤ 2 mm ) must axillary node clearance ( minimum 10 node remove ) perform No 3 pathologically involved lymph nod No internal mammary node visible sentinel node scintigraphy absence negative histology NOTE : *Isolated tumor cell count micrometastases Underwent total mastectomy ( minimum 1 mm margin clear invasive cancer DCIS ) axillary surgery staging procedure Must undergone adjuvant systemic chemotherapy indicate intermediaterisk breast cancer Patients undergo immediate breast reconstruction allow No known BRCA1 BRCA2 carrier Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify Not pregnant Fit adjuvant chemotherapy , adjuvant endocrine therapy , postoperative radiotherapy No prior concurrent malignancy except curatively treat nonmelanomatous skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent trastuzumab No prior neoadjuvant systemic therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>stage II breast cancer</keyword>
</DOC>